Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sphere of biopharmaceuticals, supplying promising breakthroughs throughout various health care and industrial purposes. With its structural similarity to naturally derived human serum albumin, OsrHSA gives a safer, far more reliable alternate for therapeutic use